Profil
Andrew Khoo is the founder of Tessa Therapeutics Ltd..
He is currently the Director at Vyriad, Inc..
Mr. Khoo was previously the Director at Enleofen Bio Pte Ltd. from 2017 to 2019.
Postes actifs de Andrew Khoo
| Sociétés | Poste | Début |
|---|---|---|
Vyriad, Inc.
Vyriad, Inc. BiotechnologyHealth Technology Engages in R&D, manufacturing and clinical trials in viral therapies & genetic medicines | Directeur/Membre du Conseil | - |
Anciens postes connus de Andrew Khoo
| Sociétés | Poste | Fin |
|---|---|---|
Enleofen Bio Pte Ltd.
Enleofen Bio Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics to treat fibrosis | Directeur/Membre du Conseil | 01/01/2019 |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Vyriad, Inc.
Vyriad, Inc. BiotechnologyHealth Technology Engages in R&D, manufacturing and clinical trials in viral therapies & genetic medicines | Health Technology |
Enleofen Bio Pte Ltd.
Enleofen Bio Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics to treat fibrosis | Health Technology |
















